Scioto Biosciences

BiotechnologySeries AIndianapolis, USsciotobiosciences.com

Latest round

Series A

Last raised

May 2018

Total raised

$1.8M

Investors

3

About Scioto Biosciences

Scioto Biosciences, Inc.Founded in 2017 and headquartered in Indianapolis, US, Scioto Biosciences, Inc. develops innovative therapies leveraging beneficial bacteria for gastrointestinal health.Scioto Biosciences, Inc. specializes in Activated Bacterial Therapeutics aimed at treating gastrointestinal disorders and conditions linked to the central nervous system, particularly autism spectrum disorder (ASD).Scioto Biosciences employs a revenue model based on partnerships with healthcare providers and research institutions utilizing their proprietary products in clinical environments. They also engage in direct-to-consumer sales, especially for SB-121, which is distributed via specialized medical channels and pharmacies.5 mn in August 2020, Scioto Biosciences plans to leverage this capital to further develop their product pipeline, including upcoming launches of new therapies focused on gastrointestinal health. The company is targeting expansion into North American and European markets by mid-2023, aiming to meet the rising demand for effective interventions in ASD and GI disorders.

Who invested in Scioto Biosciences

3 investors across 1 round

See all investors in Scioto Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 8, 2018

    Amount

    $1.8M

    Investors

    Locked

Questions about Scioto Biosciences

Who invested in Scioto Biosciences?

Scioto Biosciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Scioto Biosciences raised?

Scioto Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Scioto Biosciences last raise money?

Scioto Biosciences's most recent round on record is a Series A, in May 2018.

What does Scioto Biosciences do?

Scioto Biosciences is a biotechnology company.

Where is Scioto Biosciences headquartered?

Scioto Biosciences is headquartered in Indianapolis, US.

Which VCs invest in companies like Scioto Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Scioto Biosciences's stage. Their profiles are linked below.

Raising like Scioto Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.